Literature DB >> 23514051

Laparoscopic surgery for inflammatory bowel disease--the experience in China.

Yi Han1, Mou-Bin Lin, Yong-Gang He, Hao-Bo Zhang, Ya-Jie Zhang, Lu Yin.   

Abstract

BACKGROUND: The incidence of inflammatory bowel disease (IBD) has risen rapidly in China over the last 15 years. Increasing numbers of people with IBD require surgery during their lifetime, but few reports of IBD in Eastern populations have been described to date. The aim of this study was to assess the short-term effects of the laparoscopic surgery for IBD in Chinese patients.
MATERIALS AND METHODS: From February 2010 to March 2012, 35 patients with IBD underwent laparoscopic operations and the clinical data obtained for these patients were reviewed.
RESULTS: Patients with Crohn's disease (CD) (N = 21) and ulcerative colitis (UC) (N = 14) underwent laparoscopic surgery. In the CD group, the mean age was 37.4 years. Two patients (9.5%) required conversion to an open procedure. The median length of postoperative hospitalization was 9 (7-40) days. Overall morbidity was 26.3% and no patients required re-operation. In the UC group, the mean age was 55.2 years. The conversion rate was 14.3% (2/14). The median time to regular diet was 4 (3-10) days and the median length of postoperative hospitalization was 8 (7-25) days. Four patients developed postoperative complications and one patient developed ileostomy retraction requiring urgent operative intervention to rebuild the stoma.
CONCLUSIONS: Laparoscopic surgery in patients with IBD can be accomplished safely and with reasonable operative times, conversion rates and morbidity rates. The main advantages of the laparoscopic approach are rapid recovery, improved cosmesis, less postoperative pain, and patient satisfaction.

Entities:  

Mesh:

Year:  2013        PMID: 23514051     DOI: 10.3109/08941939.2012.732664

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  2 in total

1.  Surgical management of inflammatory bowel disease in China: a systematic review of two decades.

Authors:  Qiao Yu; Ren Mao; Lei Lian; Siew Chien Ng; Shenghong Zhang; Zhihui Chen; Yanyan Zhang; Yun Qiu; Baili Chen; Yao He; Zhirong Zeng; Shomron Ben-Horin; Xinming Song; Minhu Chen
Journal:  Intest Res       Date:  2016-10-17

2.  Effect of Loureirin B on Crohn's disease rat model induced by TNBS via IL-6/STAT3/NF-κB signaling pathway.

Authors:  Xueliang Sun; Ke Wen; Zhizhong Xu; Zongqi He; Bensheng Wu; Xiao Yang; Xiaopeng Wang
Journal:  Chin Med       Date:  2020-01-06       Impact factor: 5.455

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.